The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Front Endocrinol (Lausanne). 2020 Nov 10;11:553288. doi: 10.3389/fendo.2020.553288. eCollection 2020.
Chinese medicine has been used to treat diabetes symptoms for thousands of years. or is a Chinese medicinal herb that is routinely used in the treatment of diabetes mellitus (DM).
The purpose of this study is to evaluate the evidence of the added benefits and safety of herbal formulae containing in clinical studies and the possible mechanisms of in the prevention and treatment of DM in experimental studies.
We searched nine databases for randomized controlled trials (RCTs) that included in the formulae in the treatment of type 2 DM. Furthermore, experimental studies on the prevention and treatment of DM by in English- and Chinese-language databases were identified.
Fifty-three moderate quality RCTs with herbal formulae containing were identified. Results from meta-analysis indicated that alone or formulae containing in addition to conventional treatments could benefit people with type 2 DM in lowering blood glucose, blood lipids and reducing insulin resistance. Moreover, adverse events were significantly lower in the CHM plus conventional group than those in the conventional group. may exert the benefit through various mechanisms including inhibition of -glucosidase and DPP-IV activity, increase of endogenous GLP-1 and immune regulating activities.
Evidence from this review suggested that there appeared to be added clinical benefits associated with the use of for DM, whether as a food supplement or as a CHM combined with hypoglycemic agents with a good safety profile.
中药治疗糖尿病已有数千年的历史。黄连是一种中药,常用于治疗糖尿病(DM)。
本研究旨在评估含有黄连的中药方剂在临床研究中的附加益处和安全性的证据,以及黄连在实验研究中预防和治疗 DM 的可能机制。
我们在九个数据库中搜索了包含黄连的中药方剂治疗 2 型 DM 的随机对照试验(RCT)。此外,还在英文和中文数据库中确定了关于黄连预防和治疗 DM 的实验研究。
共确定了 53 项中等质量的 RCT,其中包含黄连的中药方剂。荟萃分析结果表明,黄连单独或与常规治疗联合使用,可降低 2 型 DM 患者的血糖、血脂和胰岛素抵抗。此外,中药加常规组的不良事件发生率明显低于常规组。黄连可能通过抑制 -葡萄糖苷酶和 DPP-IV 活性、增加内源性 GLP-1 和免疫调节活性等多种机制发挥作用。
本综述的证据表明,黄连无论是作为食品补充剂还是与降糖药联合使用,都可能对 DM 有临床附加益处,且安全性良好。